Home › Funds › Duquesne Family Office LLC › TEVA

Duquesne Family Office LLC position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

Duquesne Family Office LLC reported holding 624,999 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q2 2026 13F filing — a position valued at US$21.2M, representing 0.47% of its reported portfolio and ranking #50 among its reported holdings. Duquesne Family Office LLC has disclosed TEVA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)625.00K sh
Reported value held$21.18M
Portfolio Weight0.47%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Duquesne Family Office LLC's TEVA position evolved

Duquesne Family Office LLC first disclosed a stake in TEVA in Q3 2024 at 1,427,950 shares (US$25.7M). The position peaked in Q3 2025 at 16,593,935 shares, worth US$335.2M. Across 8 filings, Duquesne Family Office LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 624,999 shares valued at US$21.2M — a reduction of -1,752,286 shares quarter over quarter.. Notable position changes include a 530% increase in Q4 2024 (shares fell 30% over the following quarter), a 65% increase in Q1 2025 (shares rose 9% over the following quarter), a 74% trim in Q2 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.43M $25.73M New
Q4 2024 9.00M $198.30M Add
Q1 2025 14.88M $228.70M Add
Q2 2025 15.97M $267.64M Add
Q3 2025 16.59M $335.20M Add
Q4 2025 5.87M $183.35M Reduce
Q1 2026 2.38M $71.60M Reduce
Q2 2026 625.00K $21.18M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 43 other funds we track also report a position in TEVA — the largest reported positions include Harel Insurance Investments & Financial Services Ltd. (US$1.63B), Phoenix Financial Ltd. (US$1.45B), WCM INVESTMENT MANAGEMENT, LLC (US$1.38B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has Duquesne Family Office LLC held TEVA?

Duquesne Family Office LLC has disclosed TEVA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Duquesne Family Office LLC's current position in TEVA?

As of Q2 2026, Duquesne Family Office LLC holds 625.00K shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $21.18M, representing 0.47% of its reported portfolio and ranking #50.

Has Duquesne Family Office LLC been buying or selling TEVA?

In the latest 13F filing (Q2 2026), Duquesne Family Office LLC reduced its position in TEVA. The position peaked in Q3 2025 at 16.59M shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include Harel Insurance Investments & Financial Services Ltd., Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.